Type 2 Transaction (List 1). DOD Biotech Public Company Limited (the “Company”) hereby notifies the significant resolutions passed by the Board of Directors’ Meeting No. 8/2018, held on December 19, 2018
(2004), dated October 29, 2004 and its amendments. The detail of this transaction is as follows : 1. Transaction Date Wattanapat Samui Hospital is in stage of study for forecasting the Environmental
Total shareholders’ equity 55,958 56,771 58,009 60,959 Total liabilities and shareholders’ equity 116,864 109,518 106,031 107,105 5. Total Value of Consideration 5.1 The Shares Purchase Transaction The
Total shareholders’ equity 55,958 56,771 58,009 60,959 Total liabilities and shareholders’ equity 116,864 109,518 106,031 107,105 5. Total Value of Consideration 5.1 The Shares Purchase Transaction The
vehicle segment and commercial vehicle segment by 23.6% and 24.4% yoy respectively. In the equity market, the average daily turnover (SET and mai) for 1Q20 increased by 25.8% from Baht 53,192 million in
passenger vehicle segment and commercial vehicle segment by 7.8% and 15.9% yoy respectively. In the equity market, the average daily turnover (SET and mai) for 1Q20 increased by 25.8% from Baht 53,192 million
Type 2 Transaction (List 1). DOD Biotech Public Company Limited (the “Company”) hereby notifies the significant resolutions passed by the Board of Directors’ Meeting No. 8/2018, held on December 19, 2018
Operating Debt to Equity (times) 0.39 0.54 0.80 (51)% 0.39 0.80 (51)% 1Consolidated financials are based upon elimination of intra-company (or intra-business segment) transactions 2Total of each segment may
% or THB 13,902mn from 31 December 2017, mostly from the EBT of UE, which was funded by a capital increase via issuance of preferred shares in the first quarter Net debt to equity ratio as of 31
generation capacity and 10 tons per hour of steam generation capacity with the project cost of approximately Baht 3,105 million (the debt proportion is approximately 75 percent and the equity proportion is